PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.44%
R&D change of 0.44% versus flat Healthcare spending. Walter Schloss would verify adequacy.
34.62%
G&A change of 34.62% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
No Data
No Data available this quarter, please select a different quarter.
-26.41%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
14.45%
Operating expenses change of 14.45% versus flat Healthcare costs. Walter Schloss would verify control.
14.45%
Total costs change of 14.45% versus flat Healthcare costs. Walter Schloss would verify control.
561.32%
Interest expense change of 561.32% versus flat Healthcare costs. Walter Schloss would verify control.
-26.41%
D&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency.
55.40%
EBITDA growth while Healthcare declines. Peter Lynch would examine advantages.
No Data
No Data available this quarter, please select a different quarter.
-14.45%
Operating income decline while Healthcare median is -0.64%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
231.19%
Other expenses change of 231.19% versus flat Healthcare. Walter Schloss would verify control.
43.33%
Pre-tax income growth while Healthcare declines. Peter Lynch would examine advantages.
No Data
No Data available this quarter, please select a different quarter.
561.32%
Tax expense change of 561.32% versus flat Healthcare. Walter Schloss would verify strategy.
43.33%
Income change of 43.33% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
43.35%
EPS change of 43.35% versus flat Healthcare. Walter Schloss would verify quality.
43.35%
Diluted EPS change of 43.35% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.